Jul 08, 2011
Notice
Kringle Initiates Phase I Clinical Trial of Recombinant Human HGF for the Treatment of Incurable Neuronal Diseases.
Kringle Initiates Phase I Clinical Trial of Recombinant Human HGF for the Treatment of Incurable Neuronal Diseases.